MTOR and neoplasm: In hormone-dependent cancers, such as breast cancer, CTSD promotes tumor cell proliferation and apoptosis through through various mechanisms, including the regulation of PI3K-mTOR signaling [168, 169], recruitment of immune cells like M2 macrophages, and inhibition of NK cells, all of which remodel the tumor microenvironment to promote tumor growth [170].